FinancingRegulatory filing
What was reported
On August 19, 2026, Nexalin Technology, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell to such Investor in a registered direct offering 2,419,355 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, at an offering price of $0.31 per share (such registered direct offering, the “Registered Offering”).U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · Aug 20, 2026 · Open the source ↗
What the evidence supports
Nexalin Technology told the SEC (Form 8-K, Item 1.01) that it entered into a financing arrangement or sold its securities. The filing gives Aug 19, 2026 as the date of the earliest event reported.
What remains unknown
How much money will actually be raised or drawn, at what final price, and how it will be used beyond what the company stated. Stated amounts can be maximums or targets rather than money already received.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $750,000 | “The gross proceeds to the Company from the Registered Offering are expected to be approximately $750,000, before deducting offering expenses payable by the Company.” Mentions: offering, proceeds, expenses |
| $604,839 | “In addition, if the holders of the Common Warrants exercise such warrants in full for cash, the Company would receive additional gross proceeds of approximately $604,839.” Mentions: proceeds, cash |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Form 8-K, Item 1.01 textOn August 19, 2026, Nexalin Technology, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell to such Investor in a registered direct offering 2,419,355 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, at an offering price of $0.31 per share (such registered direct offering, the “Registered Offering”).U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · Aug 20, 2026 · Open the source ↗
Amount stated in the filingThe gross proceeds to the Company from the Registered Offering are expected to be approximately $750,000, before deducting offering expenses payable by the Company.U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · Aug 20, 2026 · Open the source ↗
Amount stated in the filingIn addition, if the holders of the Common Warrants exercise such warrants in full for cash, the Company would receive additional gross proceeds of approximately $604,839.U.S. Securities and Exchange Commission (EDGAR) · 8-K: 8-K · Aug 20, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:54 UTC
Nexalin Technology reports entry into a material definitive agreement (Form 8-K, Item 1.01)
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.